Assessment of 3M Oedema Reduction System in the Treatment of Lymphoedema Compared to Commercial Short-stretch Bandage

Exclusion Criteria

• •Known pregnancy
• •Evidence of active cancer, either local or metastatic
• •A period of intense daily bandaging within the last month
• •Decompensated heart failure or clinically relevant kidney or liver disease
• •Known relevant arterial disease of the arms
• •Deep vein thrombosis or phlebitis in the last 3 months
• •Paralysis of the arms
• •Clinical infection of the arms (e.g. erysipelas)
• •Wounds located at the study arm that require dressing change more than once a week
• •History of allergic reactions to study material
• •Participation in any prospective clinical study that can potentially interfere with this study
• •Known pregnancy
• •Evidence of active cancer, either local or metastatic
• •A period of intense daily bandaging within the last month
• •Decompensated heart failure or clinically relevant kidney or liver disease
• •Deep vein thrombosis or phlebitis in the last 3 months
• •Known relevant arterial disease of the legs
• •Paralysis of the legs
• •Clinical infection of the legs (e.g. erysipelas)
• •Circumferential Lymphorrhoea
• •Wounds located at the study leg that require dressing change more than once a week
• •History of allergic reactions to study material
• •Participation in any prospective clinical study that can potentially interfere with this study